By Sage Mercer, Top Shelf Mushrooms Editorial Desk
Reishi is called the “mushroom of immortality” in traditional Chinese medicine — a title that has been borrowed enthusiastically by modern supplement marketers. Strip away the mythology, and you find something genuinely interesting: one of the most studied medicinal mushrooms in the world, with a real and documented biological profile. Here’s what the research actually shows.
What Reishi Is
Ganoderma lucidum is a bitter, woody shelf mushroom that grows on hardwood trees across Asia. It’s virtually inedible as a food due to its tough texture and intensely bitter taste — traditionally prepared as a tea or decoction, and now commonly found in supplement form as an extract. It has been central to Traditional Chinese Medicine for over 2,000 years, classified as a “superior herb” in the Shennong Bencao Jing (one of the oldest Chinese pharmacopoeias), with associations with longevity, vitality, and calming the spirit.
Key Compounds
Reishi’s pharmacological activity comes from two primary compound classes:
- Triterpenoids (ganoderic acids) — Over 100 different ganoderic acids have been identified. These bitter-tasting compounds are associated with anti-inflammatory, liver-protective, and adaptogenic effects. They appear to modulate cortisol production and stress response pathways.
- Beta-glucan polysaccharides — Reishi contains high concentrations of 1,3 and 1,6 beta-glucans that interact with immune cell receptors (particularly Toll-like receptors and Dectin-1), activating macrophages, natural killer cells, and T-lymphocyte populations.
A quality reishi extract should contain measurable, standardized quantities of both compound classes. Products standardized only to polysaccharides may be missing the triterpenoid fraction responsible for adaptogenic effects.
Adaptogenic Effects: What “Adaptogen” Actually Means
“Adaptogen” has become a marketing buzzword, but it has a defined meaning in pharmacology: a substance that helps the body resist and recover from physical, chemical, and biological stressors — primarily by modulating the hypothalamic-pituitary-adrenal (HPA) axis and the sympathoadrenal system, which govern cortisol release and stress response.
Reishi fits this definition better than many substances carrying the label. Animal studies have consistently demonstrated cortisol-modulating effects. Human research is more limited but suggestive.
Human Clinical Research
Stress and fatigue: A 2012 randomized controlled trial (Tang et al., Phytotherapy Research) in breast cancer patients undergoing chemotherapy found that reishi supplementation significantly reduced fatigue scores and improved quality of life measures compared to placebo. This is a specific clinical population, but the mechanism — cortisol and stress pathway modulation — is relevant to general wellness applications.
A 2005 study (Zhao et al.) found that reishi polysaccharides reduced self-reported fatigue and improved mood in patients with neurasthenia over an 8-week period. Again, studied in a clinical population — generalizability to healthy individuals requires caution.
Immune function: Multiple human studies have examined reishi’s effects on immune cell populations. A meta-analysis (Jin et al., 2016, PLOS ONE) analyzed six randomized controlled trials and found that reishi supplementation was associated with enhanced T-lymphocyte activity. Effect sizes were modest and study quality was variable, but the direction of evidence is consistent.
Sleep quality: Several studies have explored reishi’s effects on sleep, based on its traditional use as a calming agent and its observed effects on the autonomic nervous system. Results are mixed; some studies show improved sleep quality measures, others show minimal effect. This is an area where more rigorous human research is needed.
Evidence grade overall: Reishi has more and better human clinical data than most functional mushrooms. The immune-support evidence is the strongest. The stress/fatigue research is promising but much of it comes from clinical populations. The sleep evidence is early and mixed.
What Supplement Labels Should Show
Quality markers for reishi supplements:
- Dual extraction — Beta-glucans are water-soluble; ganoderic acids require alcohol extraction. A product that’s only water-extracted may be missing the triterpenoid fraction. Look for dual-extraction (hot water + ethanol) labeling, or standardization to both polysaccharides AND triterpenoids.
- Fruiting body sourcing — The fruiting body contains the highest concentrations of both compound classes. Mycelium-on-grain products are lower quality for reishi specifically.
- Polysaccharide standardization — Typically expressed as a percentage (e.g., “standardized to 30% polysaccharides”)
- Triterpenoid standardization — Less common on labels but important; some products specify “ganoderic acid” content
Safety and Considerations
Reishi is generally well-tolerated in published research. At high doses or with long-term use, some individuals report digestive discomfort or mild liver enzyme elevation (rare, and typically at doses far above typical supplement levels).
Important interactions to discuss with a healthcare provider: blood thinners (reishi may have mild anticoagulant properties), immunosuppressant medications, and diabetes medications (reishi may have mild blood sugar effects).
Summary
Reishi has a legitimate, well-researched biological profile. Its adaptogenic and immune-modulatory effects are backed by plausible mechanisms and a meaningful body of human research — more so than most mushrooms in this category. The strongest evidence is for immune support and fatigue reduction in clinical populations. The calming and sleep-support effects widely marketed in supplements have biological plausibility but more limited direct human trial support. Quality matters significantly: dual extraction and fruiting body sourcing are important for ensuring both compound classes are present.
Related reading: Mushrooms for Stress and Calm | Lion’s Mane Research Guide | Supplement Format Guide